Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine)
- 20 October 2005
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 242 (1-2), 1-9
- https://doi.org/10.1016/j.mce.2005.06.005
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- β-Blocker Use, BMD, and Fractures in the Study of Osteoporotic FracturesJournal of Bone and Mineral Research, 2005
- BETA‐BLOCKER USE, BONE MINERAL DENSITY, AND FRACTURE RISK IN OLDER WOMEN: RESULTS FROM THE EPIDEMIOLOGIE DE L'OSTÉOPOROSE PROSPECTIVE STUDYJournal of the American Geriatrics Society, 2005
- Capsaicin-Sensitive Sensory Neurons Contribute to the Maintenance of Trabecular Bone IntegrityJournal of Bone and Mineral Research, 2005
- Weight gain in childhood and bone mass in female college studentsJournal of Bone and Mineral Metabolism, 2005
- Depression and Bone Mineral Density in Young Adults: Results From NHANES IIIPsychosomatic Medicine, 2004
- Psychotropic medication in pregnancyAdvances in Psychiatric Treatment, 2004
- Bone histomorphometric and biomechanical abnormalities in mice homozygous for deletion of the dopamine transporter geneBone, 2000
- Role of the Serotonergic System in the Pathogenesis of Major Depression and Suicidal BehaviorNeuropsychopharmacology, 1999
- Mechanically regulated expression of a neural glutamate transporter in bone: A role for excitatory amino acids as osteotropic agents?Bone, 1997
- Excretion of Fluoxetine and Its Metabolite, Norfluoxetine, in Human Breast MilkThe Journal of Clinical Pharmacology, 1996